GSK said it expects to take a charge of £1.8 billion ($2.3 billion) in its third-quarter results in relation to the ...

Closed Loop Medicine is a TechBio company developing prescription combination drug plus software products, with the aim of ...

The right partners excel at delivering precise, targeted messages to the right audience segments. This requires deep understanding of the nuances of the healthcare environment and the right skills to ...

Another interesting finding was that the preference for hybrid meetings almost doubled between 2022 and 2023, while the ...

The way forward, then, is to deliver truly personalised medicines and care. For industry, this means developing therapies ...

Zealand Pharma has suffered another setback in its bid to bring glucagon receptor agonist dasiglucagon for ultra-rare disease ...

Eli Lilly has named Thomas Fuchs as its first-ever chief artificial intelligence officer (CAIO), bolstering the digital ...

Sage Therapeutics has said it will stop the development of dalzanemdor in Alzheimer's disease, a few months after pulling the ...

Takeda's recently approved advanced colorectal cancer therapy Fruzaqla has been rejected by NICE for use by the NHS on the ...